Cargando…

Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?

Although there are several immunotherapy approaches for the treatment of Central Nervous System (CNS) tumors under evaluation, currently none of these approaches have received approval from the regulatory agencies. CNS tumors, especially glioblastomas, are tumors characterized by highly immunosuppre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quintarelli, Concetta, Camera, Antonio, Ciccone, Roselia, Alessi, Iside, Del Bufalo, Francesca, Carai, Andrea, Del Baldo, Giada, Mastronuzzi, Angela, De Angelis, Biagio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216238/ https://www.ncbi.nlm.nih.gov/pubmed/34163465 http://dx.doi.org/10.3389/fimmu.2021.634031

Ejemplares similares

The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors
por: Del Baldo, Giada, et al.
Publicado: (2023)

Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy
por: Pellegrino, Marsha, et al.
Publicado: (2020)

CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies
por: Antonucci, Laura, et al.
Publicado: (2022)

Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management
por: Del Baldo, Giada, et al.
Publicado: (2021)

DICER1 Syndrome and Cancer Predisposition: From a Rare Pediatric Tumor to Lifetime Risk
por: Caroleo, Anna Maria, et al.
Publicado: (2021)

BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
por: Del Bufalo, Francesca, et al.
Publicado: (2018)

Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies
por: Guercio, Marika, et al.
Publicado: (2021)

The Prognostic Role of the C-Reactive Protein and Serum Lactate Dehydrogenase in a Pediatric Series of Bone Ewing Sarcoma
por: Del Baldo, Giada, et al.
Publicado: (2022)

Vemurafenib Treatment of Pleomorphic Xanthoastrocytoma in a Child With Down Syndrome
por: Petruzzellis, Giuseppe, et al.
Publicado: (2019)

Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia
por: Caruso, Simona, et al.
Publicado: (2022)

Central Nervous System Metastasis in Neuroblastoma: From Three Decades Clinical Experience to New Considerations in the Immunotherapy Era
por: Mastronuzzi, Angela, et al.
Publicado: (2022)

Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain Cancers
por: Guido, Clara, et al.
Publicado: (2022)

Unlocking the power of precision medicine for pediatric low-grade gliomas: molecular characterization for targeted therapies with enhanced safety and efficacy
por: Cipri, Selene, et al.
Publicado: (2023)

Long‐term response to crizotinib in a 17‐year‐old boy with treatment‐naïve ALK‐positive non‐small‐cell lung cancer
por: Megaro, Giacomina, et al.
Publicado: (2022)

Cancer Predisposition Syndromes Associated With Pediatric High-Grade Gliomas
por: Ceglie, Giulia, et al.
Publicado: (2020)

Molecular Characterization of Medulloblastoma in a Patient with Neurofibromatosis Type 1: Case Report and Literature Review
por: Ranalli, Marco, et al.
Publicado: (2021)

Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies
por: Manni, Simona, et al.
Publicado: (2023)

Cerebellar mutism syndrome: From pathophysiology to rehabilitation
por: Fabozzi, Francesco, et al.
Publicado: (2022)

Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts
por: Quintarelli, Concetta, et al.
Publicado: (2021)

Medulloblastoma Associated with Down Syndrome: From a Rare Event Leading to a Pathogenic Hypothesis
por: Boni, Alessandra, et al.
Publicado: (2021)

Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation
por: Weber, Gerrit, et al.
Publicado: (2021)

GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape
por: Caforio, Matteo, et al.
Publicado: (2021)

NFB-07. USE OF PEGYLATED INTERFERON α- 2b IN PEDIATRIC PATIENTS AFFECTED BY UNRESECTABLE PLEXIFORM NEUROFIBROMAS: MONOCENTRIC EXPERIENCE
por: Cacchione, Antonella, et al.
Publicado: (2020)

Role of DNA Methylation Profile in Diagnosing Astroblastoma: A Case Report and Literature Review
por: Petruzzellis, Giuseppe, et al.
Publicado: (2019)

Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas
por: Arnone, Claudia Manuela, et al.
Publicado: (2021)

Cerebrospinal Fluid Levels of AFP and hCG: Validation of the Analytical Method and Application in the Diagnosis of Central Nervous System Germ Cell Tumors
por: D’Alessandro, Annamaria, et al.
Publicado: (2021)

Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle
por: Di Ruscio, Valentina, et al.
Publicado: (2022)

CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T cells
por: Guercio, Marika, et al.
Publicado: (2020)

Full Sails against Cancer
por: Mastronuzzi, Angela, et al.
Publicado: (2022)

Multidisciplinary Management of Craniopharyngiomas in Children: A Single Center Experience
por: Del Baldo, Giada, et al.
Publicado: (2022)

How Genetics and Genomics Advances Are Rewriting Pediatric Cancer Research and Clinical Care
por: Cipri, Selene, et al.
Publicado: (2022)

SURG-03. IMMERSIVE VIRTUAL REALITY APPLICATIONS IN NEUROSURGICAL ONCOLOGY
por: Carai, Andrea, et al.
Publicado: (2020)

Molecular Landscape in Infant High-Grade Gliomas: A Single Center Experience
por: Di Ruscio, Valentina, et al.
Publicado: (2022)

Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells
por: Polito, Vinicia A., et al.
Publicado: (2019)

Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma
por: Tumino, Nicola, et al.
Publicado: (2021)

IMG-14. DEVELOPING A PREDICTIVE GRADING MODEL FOR CHILDREN WITH GLIOMAS BASED ON DIFFUSION KURTOSIS IMAGING METRICS: ACCURACY AND CLINICAL CORRELATIONS WITH SURVIVAL
por: Voicu, Ioan Paul, et al.
Publicado: (2020)

Acute Hematological Toxicity during Cranio-Spinal Proton Therapy in Pediatric Brain Embryonal Tumors
por: Vennarini, Sabina, et al.
Publicado: (2022)

Targeting hypoxia in tumor: a new promising therapeutic strategy
por: Bosco, Maria Carla, et al.
Publicado: (2020)

Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant
por: de Billy, Emmanuel, et al.
Publicado: (2021)

Correction to: Targeting hypoxia in tumor: a new promising therapeutic strategy
por: Bosco, Maria Carla, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u2cn3ac89i56m59o4mra8fvhmm